Cryo-Cell executive pay wins 6.66M advisory votes

The votes included ratification of WIPFLI LLC for the fiscal year ending November 30, 2026, and a non-binding executive-compensation resolution.

Rhea-AI Filing Summary

Cryo-Cell International, Inc. reported results from its October 27, 2026 annual meeting, where stockholders voted on four director candidates, auditor ratification and a non-binding advisory resolution on named executive officer compensation. David Portnoy received 6,474,964 votes for and 1,215,273 withheld; Harold Berger received 7,121,908 for and 568,329 withheld; Mark Portnoy received 6,496,862 for and 1,193,375 withheld; and Daniel Mizrahi received 7,152,068 for and 538,169 withheld.

WIPFLI LLC’s appointment as independent registered public accounting firm for the fiscal year ending November 30, 2026 received 7,578,019 votes for, 4,178 against and 108,040 abstentions. The executive-compensation resolution received 6,661,012 votes for, 1,028,359 against and 866 abstentions. A separate authorization concerning proxies on other properly presented business received 6,513,018 votes for, 515,442 against and 661,777 abstentions.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Votes for David Portnoy: 6,474,964 votes Votes for Harold Berger: 7,121,908 votes Votes for Mark Portnoy: 6,496,862 votes +3 more

6 metrics

Votes for David Portnoy 6,474,964 votes Director election at the October 27, 2026 annual meeting

Votes for Harold Berger 7,121,908 votes Director election at the October 27, 2026 annual meeting

Votes for Mark Portnoy 6,496,862 votes Director election at the October 27, 2026 annual meeting

Votes for Daniel Mizrahi 7,152,068 votes Director election at the October 27, 2026 annual meeting

Votes for auditor ratification 7,578,019 votes WIPFLI LLC appointment for the fiscal year ending November 30, 2026

Votes for executive-compensation resolution 6,661,012 votes Non-binding advisory resolution at the October 27, 2026 annual meeting

Key Terms

non-binding advisory resolution, independent registered public accounting firm, Withhold

3 terms

non-binding advisory resolution regulatory

"a non-binding advisory resolution regarding the compensation"

A non-binding advisory resolution is a shareholder vote that expresses investors’ opinion or recommendation but does not legally force the company to act. Think of it like a public survey: management can ignore it, but a strong vote for or against signals investor sentiment, can sway board behavior or policy decisions, and may influence market perception and future, potentially binding, actions.

independent registered public accounting firm regulatory

"as the Company's independent registered public accounting firm"

An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.

Withhold technical

"For 6,474,964 Withhold 1,215,273"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did CCEL shareholders vote on executive compensation?

CCEL’s non-binding advisory resolution on named executive officer compensation received 6,661,012 votes for, 1,028,359 against and 866 abstentions.

What were the CCEL auditor ratification vote results?

Stockholders voted to ratify WIPFLI LLC as the independent registered public accounting firm for the fiscal year ending November 30, 2026. The proposal received 7,578,019 votes for, 4,178 against and 108,040 abstentions.

How many votes did each CCEL director candidate receive?

David Portnoy received 6,474,964 votes for and 1,215,273 withheld; Harold Berger received 7,121,908 for and 568,329 withheld; Mark Portnoy received 6,496,862 for and 1,193,375 withheld; and Daniel Mizrahi received 7,152,068 for and 538,169 withheld.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/28/2026 - 05:00 PM EDT Accepted by SEC EDGAR 10/28/2026 - 05:00 PM EDT Learn about SEC filing dates

0000862692false00008626922026-10-272026-10-27

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 27, 2026

CRYO-CELL INTERNATIONAL, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-40767	22-3023093
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
700 Brooker Creek Blvd. Suite 1800
Oldsmar, Florida				34677
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 813 749-2100

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		CCEL		NYSE American LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

On October 27, 2026, Cryo-Cell International, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, stockholders voted on the election of four directors, the ratification of the appointment of WIPFLI LLC as the Company’s independent registered public accounting firm for the fiscal year ending November 30, 2026, and a non-binding advisory resolution regarding the compensation of the Company’s named executive officers.

The final voting results for each matter submitted to a vote at the Annual Meeting are set forth below.

1. Election of the Company's Board of Directors.

David Portnoy

For 6,474,964

Withhold 1,215,273

Harold Berger

For 7,121,908

Withhold 568,329

Mark Portnoy

For 6,496,862

Withhold 1,193,375

Daniel Mizrahi

For 7,152,068

Withhold 538,169

2. Ratification of the appointment of WIPFLI LLC as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2026.

For Against Abstain

7,578,019 4,178 108,040

3. Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers.

For Against Abstain

6,661,012 1,028,359 866

4. Authorization to vote the proxies upon other business properly coming before the Meeting or any adjournments or postponements thereof.

For Against Abstain

6,513,018 515,442 661,777

.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			Cryo-Cell International, Inc.
Date:	October 28, 2026	By:	/s/ David Portnoy
			David Portnoy, Chairman and Co-CEO

Filing Exhibits & Attachments

1 document

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 24.3 KB